Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
By C. Lawton. 2012
1,021 citations recorded by the source corpus.
Subfields: Biochemistry, Molecular Biology, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/3a694e0bade891d3403d81b45483a18f50fe7170
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biochemistry
- Irina Milisav
- K. Cusi
- Dusan Suput
- M. Valko
- B. Poljšak
- S. Baldelli
- Lucas B. Sullivan
- Navdeep S. Chandel
In Molecular Biology
- Lucas B. Sullivan
- K. Jomová
- Navdeep S. Chandel
- K. Fearon
- M. Valko
- S. Baldelli
- K. Aquilano
- M. Rinella
In Nutrition and Dietetics
- K. Jomová
- Irina Milisav
- Dusan Suput
- M. Valko
- B. Poljšak
- S. Baldelli
- Lucas B. Sullivan
- Navdeep S. Chandel
Citations in the corpus
- Mitochondrial reactive oxygen species and cancer (2014, result): “Contrary to the expected result, supplementation increased the risk of cancer in both cases [96,97].”
- Glutathione: new roles in redox signaling for an old antioxidant (2014, methodology): “Results obtained from randomized clinical trials, however, were inconsistent and in some circumstances have indicated that antioxidants increase cancer risk (Klein et al., 2011; Watson, 2013).”
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018, background): “6 per 1,000 person-years of vitamin E use),((189)) and this risk may be modified by baseline selenium concentration((190)) or genetic variants associated with vitamin metabolism.”
- EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. (2014, methodology): “However, the prospective randomized Selenium and Vitamin E Cancer Prevention Trial (SELECT) included 35 533 men with prostate-specific antigen (PSA) 4 ng/ml and randomized the men in the four arms to be treated with either selenium, vitamin E, selenium plus vitamin E, or placebo, with a reduction in”
- ESPEN guidelines on nutrition in cancer patients. (2017, background): “Neither long-term supplementation with vitamin E (400 IU/day) nor selenium (200 mg from selenomethionine) had a beneficial effect on incidence of prostate cancer [144].”
- The Impact of Oxidative Stress and Inflammation on RPE Degeneration in Non-neovascular AMD (2017, background): “For example, vitamin E was associated with heart failure in patients with vascular disease or diabetes mellitus in the Heart Outcomes Prevention Evaluation Study (Lonn et al., 2005) and increased prostate cancer after 7 years in the Selenium and Vitamin E Cancer Prevention Trial (Klein et al., 2011)”
- Nutrition and physical activity guidelines for cancer survivors (2012, background): “In addition, the recent Selenium and Vitamin E Cancer Prevention Trial (SELECT) found that men who were assigned supplemental selenium or vitamin E had a higher incidence of diabetes and prostate cancer, respectively.(153) Some observational studies have reported that breast cancer survivors have hi”